NCT05527717View on ClinicalTrials.gov

Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

PHASE4RecruitingINTERVENTIONAL
Enrollment

560

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Cardiogenic ShockAcute Myocardial InfarctionMulti Vessel Coronary Artery DiseaseExtracorporeal Membrane Oxygenation
Interventions
PROCEDURE

Culprit lesion only PCI

"Randomization will be done after coronary angiography before or during primary PCI for IRA. Patients will be randomized to either immediate multi-vesesl PCI group or culprit-lesion only PCI group with 1:1 ratio.~This group will be taken culprit-lesion only PCI during primary PCI."

PROCEDURE

Immediate multi-vessel PCI

"Randomization will be done after coronary angiography before or during primary PCI for IRA. Patients will be randomized to either immediate multi-vesesl PCI group or culprit-lesion only PCI group with 1:1 ratio.~This group will be taken immediate multi-vesesl PCI during primary PCI."

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER